Celltrion reported KRW829.07B in Cash and Equivalent for its fiscal quarter ending in March of 2025.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
Avita Medical AUD 14.05M 3.4M Dec/2024
Celltrion KRW 829.07B 829.07B Mar/2025
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Moderna USD 1.28B 344M Jun/2025
Organon & Co USD 599M 52M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Tectonic Therapeutic USD 287.38M 146.14M Jun/2025
Viatris USD 566.4M 188.6M Jun/2025
Xeris Pharmaceuticals USD 59.28M 12.34M Jun/2025